Luspatercept for Myelodysplastic Syndrome User Reviews
Brand names: Reblozyl
Luspatercept has an average rating of 8.8 out of 10 from a total of 5 reviews for the treatment of Myelodysplastic Syndrome. 80% of reviewers reported a positive experience, while 0% reported a negative experience.
- Melody
- March 12, 2024
Reblozyl (luspatercept) "This drug, when added to my treatment, gave me my life back. Only have to go to Moffitt for treatment every 12 weeks! No more blood transfusions or being hospitalized."
- Mark
- Taken for 1 to 6 months
- December 15, 2023
Reblozyl (luspatercept) "The side effects are kicking my butt, but hemoglobin is going up with each 3-week shot! Received the 4th dose of shots but have no stamina at all!"
- Anonymous
- Taken for 1 to 6 months
- December 23, 2023
"Noted cough and joint pain during treatment, no other symptoms."
- LSR
- Taken for 1 to 6 months
- November 8, 2023
"Neck and back of head pain continually Headache Hemoglobin went up but can’t stand the back of head and neck pain"
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about luspatercept
- Check interactions
- Compare alternatives
- Reviews (6)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous erythropoiesis agents
- Breastfeeding
- En español
Reblozyl (luspatercept) "Incredible results. Initially, the low dose was every 3 weeks, extended to 6 weeks with stable hemoglobin levels. Light side effects, although more nuanced after 7 months of the treatment, it seems. I am seeking information about the duration of the side effects and the possible increase over time."